---
title: "Analysts Offer Insights on Healthcare Companies: Bioventus (BVS) and Elanco Animal Health (ELAN)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287451952.md"
description: "Analysts Offer Insights on Healthcare Companies: Bioventus (BVS) and Elanco Animal Health (ELAN)"
datetime: "2026-05-24T07:17:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287451952.md)
  - [en](https://longbridge.com/en/news/287451952.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287451952.md)
generator: "portal-rs"
---

# Analysts Offer Insights on Healthcare Companies: Bioventus (BVS) and Elanco Animal Health (ELAN)


### Related Stocks

- [BVS.US](https://longbridge.com/en/quote/BVS.US.md)
- [ELAN.US](https://longbridge.com/en/quote/ELAN.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)

## Related News & Research

- [Top Executive Quietly Boosts Stake in Elanco Animal Health](https://longbridge.com/en/news/296293784.md)
- [Elanco Animal Health (ELAN) Lifted Guidance, Is The 21% Discount Still There?](https://longbridge.com/en/news/296298826.md)
- [Elanco director Lawrence Kurzius acquires 40,000 common shares for $935,920](https://longbridge.com/en/news/296649591.md)
- [Elanco GC, Corporate Secretary Shiv O’Neill buys 3,998 common shares for $94,278.84](https://longbridge.com/en/news/296267436.md)
- [Morgan Stanley Reaffirms Their Hold Rating on Elanco Animal Health (ELAN)](https://longbridge.com/en/news/295407468.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**